Sage Therapeutics, Inc. 4 SEC Filings

Filed On	Filing
31 Jul 2025	Form 4: Federer Jessica, Director Disposed of 21,500 Stock Option (Right to Buy) (Disposition to Issuer)
31 Jul 2025	Form 4: Quirk Michael C., See Remarks Returned 32,961 shares to the issuer · Disposed of 40,000 Stock Option (Right to Buy) (Disposition to Issuer)
31 Jul 2025	Form 4: Benecchi Christopher, Chief Operating Officer Returned 64,428 shares to the issuer · Disposed of 52,500 Stock Option (Right to Buy) (Disposition to Issuer)
31 Jul 2025	Form 4: Cola Michael F, Director Disposed of 21,500 Stock Option (Right to Buy) (Disposition to Issuer)
31 Jul 2025	Form 4: Golumbeski George, Director Disposed of 8,000 shares (Tender Offer) · Disposed of 35,093 Stock Option (Right to Buy) (Disposition to Issuer)
31 Jul 2025	Form 4: Barrett Elizabeth A., Director Disposed of 3,000 shares (Tender Offer) · Disposed of 21,500 Stock Option (Right to Buy) (Disposition to Issuer)
31 Jul 2025	Form 4: Germano Geno J, Director Disposed of 21,500 Stock Option (Right to Buy) (Disposition to Issuer)
31 Jul 2025	Form 4: Frates James M, Director Disposed of 2,845 shares (Tender Offer) · Disposed of 40,654 Stock Option (Right to Buy) (Disposition to Issuer)
31 Jul 2025	Form 4: Shiferman Gregory L., See Remarks Disposed of 7,215 shares (Tender Offer) · Returned 23,735 shares to the issuer · Disposed of 38,000 Stock Option (Right to Buy) (Disposition to Issuer)
31 Jul 2025	Form 4: Greene Barry E, Director Disposed of 46,940 shares (Tender Offer) · Returned 53,229 shares to the issuer · Disposed of 174,000 Stock Option (Right to Buy) (Disposition to Issuer)
26 Jun 2025	Form 4: Shiferman Gregory L., See Remarks Gave up 79 shares to cover exercise price or tax ($728)
26 Jun 2025	Form 4: Quirk Michael C., See Remarks Gave up 113 shares to cover exercise price or tax ($1.04K)
13 Jun 2025	Form 4: Germano Geno J, Director Granted 21,500 Stock Option (Right to Buy)
13 Jun 2025	Form 4: Golumbeski George, Director Granted 21,500 Stock Option (Right to Buy)
13 Jun 2025	Form 4: Frates James M, Director Granted 21,500 Stock Option (Right to Buy)
13 Jun 2025	Form 4: Federer Jessica, Director Granted 21,500 Stock Option (Right to Buy)
13 Jun 2025	Form 4: Cola Michael F, Director Granted 21,500 Stock Option (Right to Buy)
13 Jun 2025	Form 4: Barrett Elizabeth A., Director Granted 21,500 Stock Option (Right to Buy)
11 Apr 2025	Form 4: Shiferman Gregory L., See Remarks Received 525 shares as a grant or award · Gave up 176 shares to cover exercise price or tax ($1.22K)
11 Apr 2025	Form 4: Benecchi Christopher, Chief Operating Officer Received 5,967 shares as a grant or award · Gave up 1,454 shares to cover exercise price or tax ($10K)

Comments